These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12899858

  • 1. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
    McKee JR, Sunder TR, FineSmith R, Vuong A, Varner JA, Hammer AE, Barrett PS.
    Epilepsy Behav; 2003 Aug; 4(4):386-94. PubMed ID: 12899858
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
    Sunder TR, McKee JR, Hammer AE, Vuongc A.
    Curr Med Res Opin; 2006 Apr; 22(4):693-702. PubMed ID: 16684430
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 4. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
    McKee JR, Sunder TR, Vuong A, Hammer AE.
    J Child Neurol; 2006 May; 21(5):372-9. PubMed ID: 16901441
    [Abstract] [Full Text] [Related]

  • 5. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
    Kaminow L, Schimschock JR, Hammer AE, Vuong A.
    Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation.
    Gidal BE, Walker JK, Lott RS, Shaw R, Speth J, Marty KJ, Rutecki P.
    Seizure; 2000 Mar; 9(2):131-6. PubMed ID: 10845738
    [Abstract] [Full Text] [Related]

  • 7. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
    Fakhoury TA, Miller JM, Hammer AE, Vuong A.
    Drugs Aging; 2008 Mar; 25(11):955-62. PubMed ID: 18947263
    [Abstract] [Full Text] [Related]

  • 8. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
    Ettinger AB, Kustra RP, Hammer AE.
    Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
    [Abstract] [Full Text] [Related]

  • 9. Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy.
    Labiner DM, Ettinger AB, Fakhoury TA, Chung SS, Shneker B, Tatum Iv WO, Mitchell Miller J, Vuong A, Hammer AE, Messenheimer JA.
    Epilepsia; 2009 Mar; 50(3):434-42. PubMed ID: 19016830
    [Abstract] [Full Text] [Related]

  • 10. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT, Leroy R, Van Cott A, Hammer AE, Vuong A, Huffman R, VanLandingham K, Messenheimer JA.
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
    Kustra RP, Meador KJ, Evans BK, Leschek-Gelman LM, Groenke DA, Hammer AE, Nanry KP, Messenheimer JA, TARGET Study Group.
    Seizure; 2005 Jun; 14(4):254-61. PubMed ID: 15911360
    [Abstract] [Full Text] [Related]

  • 12. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
    Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA.
    Neurology; 2005 Dec 13; 65(11):1737-43. PubMed ID: 16344515
    [Abstract] [Full Text] [Related]

  • 13. Lamotrigine extended-release as adjunctive therapy for partial seizures.
    Naritoku DK, Warnock CR, Messenheimer JA, Borgohain R, Evers S, Guekht AB, Karlov VA, Lee BI, Pohl LR.
    Neurology; 2007 Oct 16; 69(16):1610-8. PubMed ID: 17938371
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.
    Buchanan N.
    Seizure; 1995 Sep 16; 4(3):233-6. PubMed ID: 7582659
    [Abstract] [Full Text] [Related]

  • 15. Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
    Evans BK, Kustra RP, Hammer AE.
    Am J Geriatr Pharmacother; 2007 Jun 16; 5(2):112-9. PubMed ID: 17719513
    [Abstract] [Full Text] [Related]

  • 16. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR, Goa KL.
    Paediatr Drugs; 2000 Jun 16; 2(4):299-330. PubMed ID: 10946418
    [Abstract] [Full Text] [Related]

  • 17. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A, Kulak I, Bidaut-Mazel C, Baldy-Moulinier M.
    Rev Neurol (Paris); 2001 May 16; 157(5):525-36. PubMed ID: 11438772
    [Abstract] [Full Text] [Related]

  • 18. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S, Terczynski A.
    Seizure; 2000 Oct 16; 9(7):486-92. PubMed ID: 11034873
    [Abstract] [Full Text] [Related]

  • 19. Lamotrigine in the treatment of epilepsy in people with intellectual disability.
    Besag FM.
    J Intellect Disabil Res; 1998 Dec 16; 42 Suppl 1():50-6. PubMed ID: 10030433
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T, Yamazoe T, Fujimoto A, Kobayashi R, Yokota T, Okanishi T, Uchiyama G, Ohashi T, Tanaka T, Enoki H.
    Brain Nerve; 2014 Jan 16; 66(1):59-69. PubMed ID: 24371132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.